HPV Antibody Rapid Test Reagent Stability and Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of commercially available detection systems for human papilloma virus (HPV) antibodies in body fluids, which is crucial for assessing the efficacy of HPV vaccination, as antibodies are necessary for the vaccination to be effective and proof of their presence is important for immunity confirmation.
Innovation Solution
A rapid test that involves mixing a body fluid specimen with a reagent containing a physiologically acting liquid and HPV-specific antigen, allowing for a qualitative and/or quantitative assay of antibodies, utilizing a measurable or perceivable change, such as a color reaction, to determine the presence and concentration of antibodies, which can be performed on-site without the need for expensive central laboratory analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If a rapid test is developed for HPV antibody detection, then the speed and accessibility of vaccination efficacy assessment is improved, but the complexity of creating a reliable detection system is increased
Solution Approach 1:
The detection system is segmented into distinct functional components: a sample application area, a reagent application area containing HPV-specific antigens, and a readable area for detecting antibody-antigen complex formation. This segmentation allows the complex detection task to be divided into manageable steps that can be performed sequentially, improving speed while controlling complexity through modular design
Solution Approach 2:
The patent introduces an intermediary detection system that uses HPV-specific antigens immobilized on a substrate as a mediator between the antibody in body fluid and the detection mechanism. This intermediary approach enables rapid detection without requiring complex laboratory equipment, as the antigen-antibody interaction produces a directly observable signal in the readable area
2Measurement precision
If central laboratory analysis is used for HPV antibody detection, then measurement precision is improved, but loss of time and accessibility is increased
Solution Approach 1:
The reagent containing HPV-specific antigens is prepared and immobilized on the substrate in advance, creating a pre-configured detection system. This preliminary action allows the actual detection to proceed rapidly when body fluid is applied, as the antigen is already in position to immediately bind with any antibodies present, eliminating time-consuming preparation steps while maintaining precision
Solution Approach 2:
The essential detection function is extracted from the complex central laboratory environment and transferred to a simplified rapid test format. By taking out only the critical antigen-antibody interaction component and removing unnecessary laboratory infrastructure, the system achieves both speed and precision by focusing on the core detection mechanism without extraneous complexity
3Duration of action of stationary object
If a reagent with long stability is used, then duration of action is improved, but manufacturing precision requirements are increased
Solution Approach 1:
The reagent is applied to a specific localized area on the substrate, creating a concentrated zone of HPV-specific antigens with controlled properties. This local quality approach allows the antigen to be immobilized in a defined region with consistent orientation and spacing, maintaining manufacturing precision while enabling long-term stability through controlled local conditions that protect antigen integrity
Solution Approach 2:
The detection system uses a composite structure combining the HPV-specific antigen with a stable substrate material. This composite approach enhances reagent stability by providing a protective matrix that maintains antigen activity over extended periods (4 weeks to 3 years), while the structured composite formation during manufacturing ensures consistent antigen positioning and activity through controlled assembly processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The rapid test provides reliable results within an hour, allowing for immediate detection of HPV antibodies, confirming vaccination efficacy, and can be repeated from a single specimen to ensure statistical confirmation, with the reagent maintaining reactivity for up to 4 weeks to 3 years without degrading the HPV-specific antigen.
Implementation Method 1
a reagent which essentially comprises a predetermined quantity of physiologically acting liquid and a predetermined quantity of at least one HPV-specific antigen
Data Source
AI summary
A rapid test for a qualitative and/or quantitative assay of antibodies present in body fluid against human papilloma viruses (HPV) includes mixing a specimen of body fluid with a reagent which essentially comprises a predetermined quantity of physiologically acting liquid and a predetermined quantity of at least one HPV-specific antigen. The mixture is fed to an analysis which utilizes a change that is at least one of measurable or perceivable by a user.